Register | Login

Patients for individualized clinical decision-making would fill an unmet clinical need. Activating somatic KRAS mutations are nearly omnipresent and a hallmark in the genetic make-up of pancreatic ductal adenocarcinoma (PDAC) [5]. While KRAS mutations themselves have been associated as prognostic markers, there is considerable and significant heterogeneity in the activation states of the downstrea

Who Voted for this Story



UsefulEnglish.net is an open source content management system that lets you easily create your own social network.

Username:

Password:

Remember:
Saved Stories